Literature DB >> 25847113

A maternally inherited 16p13.11-p12.3 duplication concomitant with a de novo SOX5 deletion in a male patient with global developmental delay, disruptive and obsessive behaviors and minor dysmorphic features.

Ines Quintela1, Francisco Barros2, Ramon Lago-Leston3, Manuel Castro-Gago4, Angel Carracedo1,2,5, Jesus Eiris4.   

Abstract

We detail here the clinical description and the family genetic study of a male patient with global developmental delay, disruptive and obsessive behaviors and minor dysmorphic features and a combination of two rare genetic variants: a maternally inherited 16p13.11-p12.3 duplication and a de novo 12p12.1 deletion affecting SOX5. The 16p13.11 microduplication has been implicated in several neurodevelopmental and behavioral disorders and is characterized by variable expressivity and incomplete penetrance. The causes of this variation in phenotypic expression are not fully clear, representing a challenge in genetic diagnosis and counseling. However, several authors have proposed the two-hit model as one of the underlying mechanisms for this phenotypic heterogeneity. Our data could also support this two-hit model in which the 16p13.11-p12.3 duplication might contribute to the phenotype, not only as a single event but also in association with the SOX5 deletion. The SOX5 gene plays important roles in various developmental processes and has been associated with several neurodevelopmental disorders, mainly intellectual disability, developmental delay and language and/or speech delay as well as with behavior problems and dysmorphic features. However, many of the physical features and behavioral manifestations as well as language deficiencies present in our patient are consistent with those previously reported for SOX5 deletions. Patients carrying multiple genomic variants, as the one presented here, illustrate the difficulty in analyzing genotypes when the contribution of each variant results in overlapping phenotypes and/or, alternatively, in the modification of the clinical manifestations defined by the coexisting variant.
© 2015 Wiley Periodicals, Inc.

Entities:  

Keywords:  12p12.1 deletion; 16p13.11-p12.3 duplication; SOX5; disruptive behavior; dysmorphism; global developmental delay; intellectual disability; obsessive behavior

Mesh:

Substances:

Year:  2015        PMID: 25847113     DOI: 10.1002/ajmg.a.36909

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  5 in total

Review 1.  NDE1 and NDEL1 from genes to (mal)functions: parallel but distinct roles impacting on neurodevelopmental disorders and psychiatric illness.

Authors:  Nicholas J Bradshaw; Mirian A F Hayashi
Journal:  Cell Mol Life Sci       Date:  2016-10-14       Impact factor: 9.261

2.  Single nucleotide polymorphism array in genetic evaluation of fetal ultrasound abnormalities: a retrospective follow-up study.

Authors:  Hailong Huang; Meiying Cai; Huili Xue; Liangpu Xu; Na Lin
Journal:  Am J Transl Res       Date:  2022-05-15       Impact factor: 3.940

3.  Aarskog-Scott syndrome: clinical and molecular characterisation of a family with the coexistence of a novel FGD1 mutation and 16p13.11-p12.3 microduplication.

Authors:  Piero Pavone; Silvia Marino; Antonino Maniaci; Salvatore Cocuzza
Journal:  BMJ Case Rep       Date:  2020-06-30

4.  Identification of novel genomic imbalances in Saudi patients with congenital heart disease.

Authors:  Waad Albawardi; Faten Almutairi; Zuhair N Al-Hassnan; Rawan AlMass; Albandary AlBakheet; Osama M Mustafa; Laila AlQuait; Zarghuna M A Shinwari; Salma Wakil; Mustafa A Salih; Majid Al-Fayyadh; Saeed M Hassan; Mansour Aljoufan; Osima Al-Nakhli; Brynn Levy; Balsam AlMaarik; Hana A Al-Hakami; Maysoon Alsagob; Dilek Colak; Namik Kaya
Journal:  Mol Cytogenet       Date:  2018-01-25       Impact factor: 2.009

5.  SOX5-Null Heterozygous Mutation in a Family with Adult-Onset Hyperkinesia and Behavioral Abnormalities.

Authors:  Michael Zech; Katharina Poustka; Sylvia Boesch; Riccardo Berutti; Tim M Strom; Wolfgang Grisold; Werner Poewe; Juliane Winkelmann
Journal:  Case Rep Genet       Date:  2017-10-29
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.